Briefing: Medicaid Coverage for Genomic Sequencing - July 01, 2021

This July 1, 2021, TAF briefing on Medicaid coverage for genomic sequencing provides information on why TAF wants to ensure clinicians are empowered to select whatever technology is best-suited for their individual patients by providing them with the flexibility to choose from the various diagnostic sequencing technologies. Michelle McClure from the ACMG - American College of Medical Genetics and Genomics provides information about ACMG’s new Guideline, which "makes a strong recommendation to support the use of Exome/Genome Sequencing (ES/GS) as either a first- (or second-) line test in patients with CA/DD/ID." Remy L. Brim, Ph.D. provides a legislative update and Daniel Farmer provides an overview of the CMS Early and Periodic Screening, Diagnostic and Treatment (ESPDT) benefit.